含磷嘧啶类CDK9抑制剂的分子对接、3D-QSAR和分子动力学模拟

选取64个具有潜力的含磷嘧啶类细胞周期依赖性蛋白激酶(CDK9)小分子抑制剂,采用分子对接方法研究了该类小分子与CDK9的结合作用,结果表明,分子构象、氢键形成、疏水性和氨基酸残基Cys106在此类抑制剂与CDK9的结合过程中具有重要作用.在配体叠合的基础上,运用比较分子力场分析(Co MFA)、比较分子相似性指数分析(Co MSIA)和Topomer Co MFA(T-COMFA)研究了分子结构与抑制活性的关系,发现由训练集立体场、静电场和疏水场组合的Co MSIA模型为最优模型,其内部交叉验证相关系数(Q2=0.557)、非交叉验证相关系数(R2=0.959)和外部预测相关系数(r2=0.863)具有统计学意义,该模型的三维等值线图直观显示了化合物的活性与其三维结构的关系.根据这些结果设计了10个具有新结构的含磷嘧啶类化合物,分子对接和分子动力学模拟结果表明,新化合物和CDK9的结合模式与原化合物64相同,自由能分析从理论上证明了新化合物64d的CDK9抑制活性优于化合物64,并且显示含磷基团与残基Asp109的静电场能在化合物与CDK9作用过程中有重要作用.     

应用分子图形学、分子力学、量子化学及静电势研究农药分子结构与性能关系(ΧⅢ)──用比较分子力场方法研究4-肟醚基喹唑啉类化合物的结构与抗烟草花叶病毒活性的三维构效关系

应用比较分子力场分析 (Co MFA)方法研究 4 -肟醚基喹唑啉类化合物抗烟草花叶病毒活性的三维构效关系 (3 D-QSAR) ,引入分子的摩尔折射率 (MR)和偶极矩 (DIPOLE)分别作为 Co MFA的第三和第四个场 .在此基础上进行偏最小二乘 (PLS)分析 :交叉验证 (leave-one-out)结果为 r2cv=0 .4 43 ,非交叉验证 (novalidation)结果为 r2 =0 .93 2 ,说明所建立的模型有较好的可靠性 ,并且在三维等值线图的基础上得到了一个此类化合物的模拟作用模型 ,据此可生长出一系列先导分子     

芳香噻嗪类衍生物作为选择性醛糖还原酶抑制剂的分子对接和基于受体的三维定量构效关系研究

芳香噻嗪类衍生物被证明是一类选择性较好的高活性醛糖还原酶抑制剂(ARIs).本文对44个芳香噻嗪类化合物进行了分子对接(docking)和三维定量构效关系(3D-QSAR)研究,并探索了此类化合物与醛糖还原酶(ALr²)的作用机理.醛糖还原酶与醛还原酶(ALR1)活性位点的叠加结果显示, ALr²中残基Leu 300和Cys298的存在是化合物1m具有高选择性的原因.分别建立了比较分子场分析方法(CoMFA, q² = 0.649, r² =0.934; q²:交叉验证相关系数, r²:非交叉验证相关系数)和比较分子相似性指数分析方法(CoMSIA, q² = 0.746, r² = 0.971)模型,并对影响此类化合物生物活性的结构进行了鉴定.结果显示,两个模型均具有较高预测能力,并通过测试集中的7个化合物进行了验证,其中CoMFA模型和CoMSIA模型的预测相关系数(r_Pred²)分别为0.748和0.828. 3D-QSAR模型中的三维等值线图表明,在化合物1m的苄基环上C3和C4位置以及苯并噻嗪母核上C5和C7位置进行改进可能对生物活性的提高有利,此预测与我们前期报道的苯并噻嗪母核C7位改进结果一致.本文所建3D-QSAR模型能够在理性设计具有更高生物活性的新型ARIs中发挥重要作用.     

Theoretical Studies on Quantitative Structure-Activity Relationship and Structural Modification for 3-Substituted Sulfur-5（2-Hydr0xyphenyl）-4H-1,2,4-Triazole Compounds

用DFT-B3LYP方法,在基组6-31G水平,对24种3-取代硫基-5-（2-羟基苯基）-4H-1,2,4-三唑类化合物分子进行几何优化,并计算了EHOMO,ELUMO,ENHOMO,ENLUMO,QC1～QC8,QN1～QN3,QO,QS和ΔE1,ΔE2,ΣQ等量子化学描述符（qc）.通过最佳变量子集回归建立13种上述化合物对大肠杆菌、白色念珠菌、金黄色葡萄球菌等抑菌活性（AJ：Ae,Am和As）的QSAR模型.对于大肠杆菌的Ae模型的相关系数（R2）和逐一剔除法交叉验证系数Rcv2依次为0.930和0.871,相应白色念珠菌Am模型为0.926和0.869,As模型为0.781和0.572.通过Radj2,F,Rcv2,VIF,AIC,FIT等检验,上述模型具有令人满意的稳健性和预测能力.结果显示ΔE1和ΣQ直接影响这些化合物的生物活性：ΣQ增大,其抑菌活性增强;ΔE1越高,AJ下降.据此提出三唑类化合物分子可能的抑菌机理.由此发现,在三唑类化合物分子的R中合适部位选用吸电子能力较强的取代基团进行结构修饰,有利于提高被修饰后分子的抑菌活性.根据对R进行结构修饰（共提出11种化合物）,得出4种抑菌活性均超出100%的三唑类化合物（质量分数为0.01%）,希望将来得到生物实验的证实.     

毒蕈碱受体激动剂的三维定量构效关系研究

采用比较分子场分析法(CoMFA)研究了55个四氢吡啶类毒蕈碱受体激动剂的三维定量构效关系(3D-QSAR), 建立了具有较强预测能力的3D-QSAR模型. 所得模型的交叉验证相关系数(q²)为0.507, 常规相关系数(R²)为0.982 , 标准方差为0.218, 说明系列化合物分子周围立体场和静电场的分布与生物活性间存在良好的相关性. 模型不仅很好地预测了训练集和测试集化合物的活性, 而且为设计活性更高的受体激动剂提供了理论依据.     

3-氨磺酰苯甲酸类AKR1C3抑制剂的3D-QSAR和分子对接研究

醛酮还原酶1C3(AKR1C3)作为治疗前列腺癌的新靶点已成为研究热点,3-氨磺酰苯甲酸衍生物对其具有高效的选择性和抑制活性。本文采用比较分子场分析(COMFA)和比较分子相似性指数分析(COMSIA)方法,将经分子对接后的34个优势构象组成训练集和11个优势构象组成测试集,构建三维定量构效关系(3D-QSAR)模型。COMFA模型的交叉验证系数(q2),非交叉验证系数(R2),标准偏差(SEE)和F值分别为0.761,0.973,0.122,185.963;自举法回归系数为R2bs=0.98。最佳组合COMSIA模型的q2,R2,SEE,F和R2bs分别为0.734,0.984,0.097,147.850,0.994。COMFA和COMSIA模型的系统外部测试R2pred分别为0.864和0.756,r2m分别为0.8127和0.5377。这些结果表明,所建立的QSAR模型具有较高的可靠性和较强预测能力。经三维等势图分析可知,在2、5或6位适当增加取代基体积,或在5位引入氢键受体,或在7位引入负电性取代基则能提高化合物的生物活性。该模型为进一步设计具有更优选择性和活性的化合物提供了理论依据。     

嘧啶（氧）苯甲酸类除草剂的3D—QSAR研究

利用比较分子场分析 (Co MFA)方法 ,对 2 0种嘧啶 (氧 )苯甲酸类化合物进行了三维定量构效关系(3 D-QSAR)研究。得到了具有较强预测能力的 QSAR模型。并对此模型进行了验证 ,在此基础上 ,设计了具有更高活性的化合物。     

抗癌性吲哚喹唑啉衍生物3D-QSAR研究及其分子设计

吲哚喹唑啉衍生物是近年来发现的一类具有良好抗癌活性的化合物. 作者在最近报道的二维定量构效关系(2D-QSAR)的基础上, 采用比较分子力场方法(CoMFA)进一步对该系列化合物进行三维定量构效关系(3D-QSAR)研究, 建立了3D-QSAR的CoMFA模型, 其非交叉验证相关系数r2=0.986, 标准偏差SD=0.084, 统计方差比F=114.6, 交叉验证相关系数q2=0.695, 表明该模型合理、可信, 并具有良好的预测能力. 研究结果表明: (1) 取代基R1的部位上静电效应起主要作用, 并且确保取代基R1的第一个原子具有较大的净正电荷, 对提高化合物的抗癌活性十分重要. 这与2D-QSAR研究结果相一致. (2) 取代基R2的部位上立体效应起主要作用, R2的体积大小要适中. 应用这些规律进行了分子设计, 在理论上获得了一些具有较高抗癌活性的新的吲哚喹唑啉衍生物, 并期待实验证实. 该QSAR的研究结果可为实验工作者合成新药提供理论参考.     

基于Topomer CoMFA方法的喹诺酮羧酸类衍生物的QSAR研究及分子设计

采用基于R基团搜索技术的Topomer Co MFA技术对一系列喹诺酮羧酸类衍生物进行三维定量构效(3D-QSAR)关系研究,所得模型结果的交叉验证相关系数(q2)为0.790,非交互验证系数(r2)为0.890,外部验证的复相关系数(r2pred)为0.878,研究结果表明该模型具有良好的稳定性和预测能力。采用Topomer search技术在ZINC数据库中进行虚拟筛选,筛选出6个Ra基团和3个Rb基团,进而设计出12个具有更高活性的新型喹诺酮羧酸类化合物。采用分子对接技术对药物与受体的作用机制进行了研究,结果显示,药物与蛋白酶的ASP 30、ASP 29和ASN 25位点作用明显,该QSAR的研究结果可为新药合成提供理论参考。     

二氢嘧啶并[4,5-d]嘧啶类衍生物作为集落刺激因子-1受体激酶抑制剂的分子对接和定量构效关系研究

集落刺激因子-1受体激酶(CSF-1R)属于Ⅲ型受体酪氨酸激酶家族成员,其在调控单核巨噬细胞系中发挥重要作用。CSF-1R及其配体异常表达与肿瘤发展过程密切相关。因此,CSF-1R信号传导可成为抗肿瘤治疗的有吸引力的靶标。本文用比较分子场分析法(Co MFA)和比较分子相似性指数分析法(Co MSIA)研究了54个二氢嘧啶并[4,5-d]嘧啶类CSF-1R激酶抑制剂的三维定量构效关系(3D-QSAR)。基于配体叠合,Co MFA和Co MSIA模型的交叉验证系数(q~2)分别为0. 725和0. 636,拟合验证系数(r~2)分别为0. 960和0. 958,结果表明这两种模型均具有较好的预测能力。所建模型的等势图能直观反映分子不同取代基对活性的影响,其中立体场和疏水场对活性的贡献较大。通过分子对接研究显示,氨基酸残基Cys666、Asp796在配体和受体结合过程中产生作用,分子对接的结合模式与3D-QSAR得到的结果一致。这些信息为进一步优化CSF-1R激酶抑制剂提供了理论基础。     

Antibacterial polyethylene - Ethylene vinyl acetate polymeric blend by incorporation of zinc oxide nanoparticles

In this work, a Low-Density Polyethylene (LDPE) - Ethylene Vinyl Acetate (EVA) polymeric blend with antimicrobial activity was obtained. The main objective was to develop an antibacterial LDPE-EVA polymeric blend from the incorporation of antibacterial nanoparticles to increase the antimicrobial and sanitary safety of this polymeric blend when applied in the manufacture of medical products. The antibacterial activity was obtained from the incorporation of zinc oxide nanoparticles (ZnO-NPs) in the LDPE-EVA polymeric blends and the thermal properties were evaluated by differential scanning calorimetry and the mechanical properties by tensile stress tests for different percentages of ZnO-NPs. Scanning electron microscopy was used to study the morphological characteristics of the ZnO-NPs and also the characteristics of the distribution of nanoparticles in the polymer blends. The dispersive energy of x-ray fluorescence spectroscopy was used to study the chemical composition of the nanoparticles. Microbiological tests were performed to evaluate the antibacterial activity of the LDPE-EVA polymeric blends without and with ZnO-NPs against the bacteria Staphylococcus aureus (gram-positive) and Escherichia coli (gram-negative). The results obtained were excellent for the future application of the antibacterial LDPE-EVA polymeric blends to the manufacture of medical products. The Young's modulus values decreased and the tensile strength values showed small reductions and the thermal properties of the LDPE-EVA were not modified. However, the antibacterial activity of LDPE-EVA with 4 wt% of ZnO-NPs was excellent, eliminating the gram-positive bacteria in just 2 h and the gram-negative bacteria in just 2.5 h on their surfaces.     

咪唑鎓盐系列抗菌剂的研究进展

系统介绍了基于咪唑鎓盐的有机小分子及高分子抗菌剂的研究进展,展望了该类高分子抗菌剂未来的发展方向,同时指出了紫外光固化技术在新型抗菌剂中的重要应用。     

反应性高分子抗菌剂的合成及对棉织物的抗菌整理

通过三元共聚将马来酸酐活性基团引入大分子链中,制备了两个系列的反应性高分子抗菌剂poly(DMAEMA-BC/AAm/MAn)和poly(DMAEMA-DB/AAm/MAn),并用FT-IR对合成的反应性高分子抗菌剂进行了结构表征,用酸碱滴定法测定了其酸值,通过平板活菌计数法测定了反应性高分子抗菌剂的抗菌活性,并表征了它们的抗菌活性对抗菌时间与浓度的依赖关系。通过热整理工艺将三元共聚物与棉织物反应,制得抗菌织物。之后,通过改良振荡烧瓶法测定了抗菌整理后棉织物的抗菌效果,并进一步考察了织物抗菌效果的耐洗性。研究结果表明,少量的马来酸酐(单体摩尔比5%)有助于提高共聚单体的反应活性,共聚物中含少量马来酸酐时,抗菌活性增强。用马来酸酐单体摩尔比5～35%的poly(DMAEMA-BC/AAm/MAn)或5～25%的poly(DMAEMA-DB/AAm/MAn)整理的抗菌织物均具有良好的抗菌效果,且前者经过100次水洗,后者经200次水洗后,仍表现良好的抗菌效果。     

新型抗菌高分子及其抗菌策略的研究进展

抗菌高分子具有丰富的分子结构和独特的抗菌机制。同时,对微生物具有低耐药性的倾向。这些特点使新型高分子材料在抗菌领域受到人们越来越多的关注。本文首先分析了细菌产生耐药性的原因及由其带来的严峻医学和社会问题;然后系统梳理并探讨了新型抗菌高分子材料（如树状大分子、嵌段共聚物、壳聚糖及其衍生物和抗菌高分子/纳米复合材料等）的结构特点和抗菌机理;最后展望了未来新型功能高分子在抗菌领域的重点延伸及探索方向。     

Synthesis and antimicrobial activities of novel quinazolin-4(3H)-one derivatives containing a 1,2,4-triazolo[3,4-b][1,3,4]thiadiazole moiety

A series of novel quinazolin-4(3H)-one derivatives (6a–6y) containing a 1,2,4-triazolo[3,4-b][1,3,4]thiadiazole moiety were designed and synthesized, and their structures were fully characterized by ¹H NMR, ¹³C NMR, HRMS and IR spectra. Among them, the structure of compound 6u was unambiguously confirmed via single crystal X-ray diffraction analysis. The obtained bioassay results showed that compounds 6h, 6k, 6l and 6y had the EC₅₀ (half-maximal effective concentration) values of 34.8, 28.2, 41.5 and 42.5 μg/mL against the phytopathogenic bacterium Xanthomonas oryzae pv. oryzae (Xoo), respectively, which were significantly better than commercial bactericide Bismerthiazol (EC₅₀ = 95.8 μg/mL). Additionally, compounds 6a and 6b exhibited the strong inhibition activity against the pathogen Xanthomonas axonopodis pv. citri (Xac).     

Comparative evaluation of antibacterial potentials of nano cobalt oxide with standard antimicrobials

Development of suitable potent antimicrobial is the urgent need of modern era to cope up the problem of antimicrobial resistance. The applications of nanotechnology in metal oxides have shown favorable effects to some extent in this area. Thus, the present study was investigated to evaluate the antibacterial properties of cobalt oxide (Co₃O₄) nanoparticles at different concentrations and their comparison with standard antimicrobials i.e. tetracycline and gentamicin. Nanoparticles were synthesized and characterized by standard techniques. The antibacterial potentials of Co₃O₄ nanoparticles against S. aureus and E. coli were determined at various concentrations. The maximum zone of inhibitions of Co₃O₄ nanoparticles against S. aureus and E. coli at 500 μg/ml were 21.17 mm and 24.00 mm, respectively. The Co₃O₄ nanoparticles seemed more effective than gentamicin against S. aureus and E. coli. The nanoparticles with respect to tetracycline showed higher than 1 activity index at ≥ 125 μg/ml for E. coli and ≥31.25 μg/ml for S. aureus. It was also higher than 1 at all compared concentrations with respect to gentamicin against both bacteria. In conclusion, Co₃O₄ nanoparticles seemed to have potent antibacterial potential and these might be very helpful to replace the conventional antimicrobials to solve the problem of antibacterial resistance.     

Cecropin B抗菌肽接枝丝素蛋白膜的制备和表征

以体积分数为60%的乙醇处理制得不溶性再生丝素膜, 通过碳二亚胺法将Cecropin B抗菌肽共价接枝到丝素膜表面, 利用红外光谱、扫描电镜、X射线能谱和抗菌性测试等手段对制得的丝素膜结构和表面特性及其抗菌性能进行了测试分析. 结果表明, Cecropin B抗菌肽成功地接枝到了丝素膜的表面, 接枝后的丝素膜水溶性低, 并具有良好、 持久的抗菌能力.     

First Synthesis of Some New 1-Aryl-4-ethoxycarbonyl- 5-dimethylaminomethyleneamino-1,2,- 3-triazole Under Vilsmeier Conditions

Abstract

Some new 1 - aryl - 4 - ethoxycarbonyl - 5 - dimethylaminomethyleneamino-1,2,3-triazoles were first prepared from 1-aryl-4-ethoxycarbonyl-5-amino-1,2,3-triazoles and N,N-dimethylformamide in the presence of phosphorus oxychloride under mild condition in excellent yields. Their structures were characterized by IR, ¹H NMR, MS, and elemental analysis, and their inhibiting effects on various bacteria were also screened.     

Isolation and structure determination of a new thiopeptide globimycin from Streptomyces globisporus subsp. globisporus based on genome mining

Based on genome-mining, a new thiopeptide globimycin was discovered from the extract of Streptomyces globisporus subsp. globisporus, along with known one radamycin. The structure of globimycin was established by a combination of 2D NMR and ESI-MS experiments, and globimycin was identified to be a structural isomer of a known thiopeptide methylsulfomycin. The proposed biosynthetic gene cluster for globimycin and radamycin was found in the genome of S. globisporus subsp. globisporus.     

Synthesis of Some New 4-{2-[(Aryl)amino]-1,3-thiazol4-yl}benzene-1,2-diols as Possible Antibacterial and Antifungal Agents

Some new 4-{2-[(aryl) amino]-1,3-thiazol-4-yl}benzene-1,2-diols are prepared and characterized by spectral analysis. The newly prepared compounds are studied for their antibacterial and antifungal activity. Interestingly, almost all the compounds are found to possess promising antibacterial and antifungal activity against all tested microorganisms.